Delivery Order SPE2DB22D2214-SPE2DB25FS5BJ
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PRILOSEC DR 2.5 MG SUSPENSION 30S, a pharmaceutical product, with a ceiling value of $4,235.30 and a period of performance through May 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.92 Firm Fixed Price Delivery Order is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S, a medication, with a period of performance through May 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567908468 - Prilosec DR 10 MG Suspension 30S, a pharmaceutical product. The contract has a ceiling value of $4,039.89 and runs through April 15, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $2,154.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of PRILOSEC DR 10 MG SUSPENSION 30S, a pharmaceutical product, to support military healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Prilosec DR 2.5 mg suspension medication. The contract has a total ceiling value of $3,271.65 and an ultimate completion date of January 25, 2024. It is a firm-fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $5,043.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Prilosec DR 10 mg suspension, a pharmaceutical product, to support the DLA's medical supply programs. The contract is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 and a term running through November 2026. This IDC serves as the primary...
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRYD6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,180.05 Firm Fixed Price contract is for the delivery of Prilosec DR 10 mg suspension medication. The contract has a completion date of September 20, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The $1,278.20 firm fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension products. The award does not have a set-aside designation, indicating it was made through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $7,577.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) designated as SPE2DX, which has a total potential value of $999,999,999.00 and provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government agencies through...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,198,487 units of omeprazole delayed-release 40 mg capsules. The contract has a total ceiling value of $2,256.48 and a completion date of February 7, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...